These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 19070804)
21. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
22. Plasmacytoid urothelial carcinoma of the bladder. Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008 [TBL] [Abstract][Full Text] [Related]
23. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes. Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431 [TBL] [Abstract][Full Text] [Related]
24. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology. Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894 [TBL] [Abstract][Full Text] [Related]
25. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder. Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229 [TBL] [Abstract][Full Text] [Related]
26. MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin. Chen F; Zhang G; Cao Y; Hessner MJ; See WA J Urol; 2009 Dec; 182(6):2932-7. PubMed ID: 19853870 [TBL] [Abstract][Full Text] [Related]
27. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept. Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948 [TBL] [Abstract][Full Text] [Related]
28. Shoulder pain: unusual presentation of transitional cell cancer of bladder. Butt MA ANZ J Surg; 2008 Sep; 78(9):822. PubMed ID: 18844923 [No Abstract] [Full Text] [Related]
29. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623 [TBL] [Abstract][Full Text] [Related]
30. A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma. Wülfing C; Machiels JP; Richel DJ; Grimm MO; Treiber U; De Groot MR; Beuzeboc P; Parikh R; Pétavy F; El-Hariry IA Cancer; 2009 Jul; 115(13):2881-90. PubMed ID: 19399906 [TBL] [Abstract][Full Text] [Related]
31. Granulomatous epididymo-orchitis, a rare complication of intravesical bacillus Calmette-Guérin therapy for urothelial cancer. Harving SS; Asmussen L; Roosen JU; Hermann G Scand J Urol Nephrol; 2009; 43(4):331-3. PubMed ID: 19396724 [TBL] [Abstract][Full Text] [Related]
32. Differences in tumor characteristics and prognosis in newly diagnosed Ta, T1 urothelial carcinoma of bladder according to patient age. Cho KS; Hwang TK; Kim BW; Yoon DK; Chang SG; Kim SJ; Park JY; Cheon J; Sung GT; Hong SJ; Urology; 2009 Apr; 73(4):828-32, 832.e1. PubMed ID: 19195693 [TBL] [Abstract][Full Text] [Related]
33. Second-line therapy in bladder cancer. Bachner M; De Santis M Curr Opin Urol; 2009 Sep; 19(5):533-9. PubMed ID: 19550334 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of bladder cancer. Sharma S; Ksheersagar P; Sharma P Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342 [TBL] [Abstract][Full Text] [Related]
35. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662 [TBL] [Abstract][Full Text] [Related]
36. [Skin metastases as the first manifestation of the progress of urothelial vesical carcinoma]. Donate Moreno MJ; Pastor Navarro H; Carrión López P; Salinas Sánchez AS; Lorenzo Romero JG; Ruiz Mondéjar R; Virseda Rodríguez JA Actas Urol Esp; 2007; 31(7):802. PubMed ID: 17902482 [No Abstract] [Full Text] [Related]
37. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture. Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871 [TBL] [Abstract][Full Text] [Related]
38. [Metastatic bladder metachrone to a kaposi sarcoma cancer at a therapeutic impasse: about a case]. Shamalirwa BB; Wembonyama O; Tidahy R; Mellas S; Ammari JEE; Tazi MF; Farih MH; Elmahi H; Sidibe IS Pan Afr Med J; 2019; 32():218. PubMed ID: 31312329 [TBL] [Abstract][Full Text] [Related]
39. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Tran E; Souhami L; Tanguay S; Rajan R Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080 [TBL] [Abstract][Full Text] [Related]
40. Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature. Albores-Saavedra J; Chable-Montero F; Hernández-Rodríguez OX; Montante-Montes de Oca D; Angeles-Angeles A Ann Diagn Pathol; 2009 Jun; 13(3):158-61. PubMed ID: 19433293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]